CODX
Co-Diagnostics, Inc.
Key Financials
Operating Income
$-50165352
↓ 25.2%
Net Income
$-46895936
↓ 24.6%
Total Assets
$24.7M
↓ 61.3%
EPS (Diluted)
$-35.25
↓ 2742.7%
Gross Profit
$400112
↓ 86.3%
Revenue
$622489
↓ 84.1%
Total Liabilities
$4.1M
↓ 57.5%
Shareholders' Equity
$20.6M
↓ 62.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/25/2026 | View on SEC |
| PRE 14A | 9/21/2026 | View on SEC |
| 8-K | 9/16/2026 | View on SEC |
| 8-K | 9/16/2026 | View on SEC |
| 8-K | 9/15/2026 | View on SEC |
| 3 | 9/14/2026 | View on SEC |
| 8-K | 9/4/2026 | View on SEC |
| DEFA14A | 9/4/2026 | View on SEC |
| 8-K | 9/4/2026 | View on SEC |
| EFFECT | 9/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CODX |
| Company Name | Co-Diagnostics, Inc. |
| CIK | 1692415 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | UT |
| Phone | 8014381036 |